welcomes you to the new, improved website!Cancer Research UK announced a large investment into TRACERx, a project aimed at identifying genetic abnormalities in lung cancers and following their evolution over the lifetime of the patient. Similar efforts are underway in France and the US.
The evolution of lung cancer treatment
Submitted by: Erica Curcio
Source: The Lancet
Keywords:
Author(s): Anonymous